Predictors of Myelosuppression for Patients with Head and Neck Squamous Cell Carcinoma After Induction Chemotherapy.

Wen-Qing ChenLiang PengXue-Lan ZengWei-Ping WenWei Sun

Published in: Clinical Medicine Insights. Oncology (2024)

The PLC and PPC predicted myelosuppression in patients with HNSCC-administered ICT, and the PHC predicted grades III to IV myelosuppression. Myelosuppressed patients were more chemosensitive after ICT.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
radiation therapy
squamous cell carcinoma
rectal cancer
chemotherapy induced